14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Predictions

$1.23
+0 (+0%)
At Close: May 27, 2022
Currently predicting for Mon, 6 May 2024

CTRV Predictions History

7 years ago
Angel.Reyna..5117 predicted that CTRV for 2017-03-29 is going $1.70 (-99.82%)

Rank:

7 years ago
JS predicted that CTRV for 2017-03-22 is going $1.55 (-99.82%)

7 years ago
Bonnie.Robinson.4113 predicted that CTRV for 2017-03-22 is going $1.16 (-99.87%)

Rank:

7 years ago
pty_rafa predicted that CTRV for 2017-03-22 is going $1.60 (-99.82%)

Rank:

7 years ago
Jack.Cesario.Migueis.3576 predicted that CTRV for 2017-03-22 is going $1.62 (-99.82%)

7 years ago
JS predicted that CTRV for 2016-12-20 is going $1.75 (-99.82%)

7 years ago
AJR predicted that CTRV for 2016-12-19 is going $1.85 (-99.83%)

Rank:

7 years ago
JS predicted that CTRV for 2016-12-19 is going $1.85 (-99.83%)

7 years ago
mapeki predicted that CTRV for 2016-10-25 is going $4.00 (-99.62%)

Rank:

7 years ago
Stephen predicted that CTRV for 2016-10-25 is going $2.05 (-99.80%)

Rank:
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT